Joel Greenblatt's KNSA Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 7,574 shares of Kiniksa Pharmaceuticals International, plc (KNSA) worth $364,688, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 4 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in KNSA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 912 shares. Largest reduction occurred in Q3 2025, reducing 8,331 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Kiniksa Pharmaceuticals International plc (KNSA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kiniksa Pharmaceuticals International plc (KNSA) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +912 | Add 13.69% | 7,574 | $48.15 |
| Q4 2025 | +317 | Add 5.00% | 6,662 | $41.25 |
| Q3 2025 | -8,331 | Reduce 56.77% | 6,345 | $38.83 |
| Q2 2025 | +14,676 | New Buy | 14,676 | $27.67 |
Joel Greenblatt's Kiniksa Pharmaceuticals International plc Investment FAQs
Joel Greenblatt first purchased Kiniksa Pharmaceuticals International, plc (KNSA) in Q2 2025, acquiring 14,676 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Kiniksa Pharmaceuticals International, plc (KNSA) for 4 quarters since Q2 2025.
Joel Greenblatt's largest addition to Kiniksa Pharmaceuticals International, plc (KNSA) was in Q2 2025, adding 14,676 shares worth $406,085.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 7,574 shares of Kiniksa Pharmaceuticals International, plc (KNSA), valued at approximately $364,688.
As of the Q1 2026 filing, Kiniksa Pharmaceuticals International, plc (KNSA) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Kiniksa Pharmaceuticals International, plc (KNSA) was 14,676 shares, as reported at the end of Q2 2025.